We've all experienced birth, though none of us remember it.
Only a mother can really know what it means to bring new life into this world.
These are the stories of five women from five very different places. They are hundreds of miles apart. They all speak different languages. But the journey they are about to embark on is universal to all mothers.
"I had prepared myself in a small way
in that I managed to save about
200 or 500 shillings."
Each of these stories has a happy ending, but they are a moving reminder of how different it might have been had they given birth without a skilled birth attendant.
A child’s birthplace should not dictate whether they live or die, but this global birth lottery is a tragic reality for millions.
Southern Asia and Sub-Saharan Africa, account for 77% of all newborn deaths. 99% of all maternal deaths occur in developing countries. But there are also huge inequalities within countries.
Even when good quality health care is available in the urban centres, it’s often only for those who can afford to pay for it.
For poor people, especially those living in remote, rural areas, healthcare can be practically non-existent.
UNIVERSAL HEALTH COVERAGE
Together Save the Children and GSK are calling on all governments around the world to achieve universal health coverage by 2030.
No woman should have to give birth without essential health services and no family should face financial hardship as a result.
The GSK Save the Children partnership
Save the Children and GSK have an innovative and strategic partnership. It combines our expertise, skills and energy with the ambitious goal of helping to save one million children’s lives.
We are calling for improved access to healthcare across the globe and long-term, sustainable progress towards reducing child mortality. We are also working on the ground, increasing the training, reach and scope of health workers in the poorest communities, and helping children affected by disasters and humanitarian crises.
What our partnership has achieved so far
Together, we have directly helped more than 2.83 million children in 45 countries. We have fully immunised 97,600 children and treated over 187,000 children for pneumonia, malaria or diarrhoea since 2013. We have helped over 300,000 children during and after humanitarian emergencies.
The research and development work conducted by the partnership led to GSK’s reformulation of the antiseptic chlorhexidine, commonly used in mouthwash, into an antiseptic gel, using insights and on-the-ground knowledge from Save the Children.
This gel is being used to prevent umbilical cord infection which can lead to life-threatening neonatal sepsis. So far 30,000 newborns in Bungoma County Kenya have had access to the gel.
GSK has committed to making the new formulation and quality specifications available to other manufacturers, in addition to making the medicine available on a ‘not-for-profit’ pricing basis.